2024), and the first randomized controlled trial of semaglutide in AUD found that low-dose treatment reduced alcohol craving and drinking quantity, providing evidence for its therapeutic potential (Hendershot et al
Strategy 15: Muscle Preservation for Energy Muscle tissue drives metabolic rate and supports functional energy for daily activities
It isnt suitable for people with chronic health conditions requiring more complicated care, nor is it meant for urgent concerns or emergencies
These medications appear to have benefits beyond weight loss
Consumers should set expectations accordingly
Diabetes Care 34(Supplement_2):S279-84 Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P et al (2019) Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial